Research suggests that Devil's Claw may help reduce joint pain and improve mobility in conditions such as osteoarthritis and musculoskeletal disorders, with one comparative review noting it had the strongest clinical support among eight plant-derived compounds evaluated for osteoarthritis. The available evidence includes narrative reviews synthesizing animal studies and clinical trials, along with a small observational study following 42 patients taking a combination supplement containing Devil's Claw alongside turmeric and bromelain, all of which generally point in a supportive direction. However, the limitations across this body of work are notable — the precise biological mechanisms behind Devil's Claw's effects remain incompletely understood, the observational study lacked a control group and could not isolate Devil's Claw's contribution from the other ingredients, and reviewers consistently call for larger, higher-quality randomized controlled trials before firm recommendations can be made. Studies indicate that Devil's Claw appears to be reasonably well tolerated, but the current evidence, while encouraging, should be considered preliminary rather than conclusive.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| A review of the biological and potential therapeutic actions of Harpagophytum... | Review | 2007 | Supports | 72 |
| Current nutraceuticals in the management of osteoarthritis: a review. | Other | 2012 | Supports | 67 |
| A complex of three natural anti-inflammatory agents provides relief of osteoa... | Other | 2014 | Mixed | 62 |